Carboxymethyl dextran benzylamide sulfonate/sulfates (CMDBS) are synth
etic polysaccharides with anticoagulant activity. We synthesized eight
different highly substituted CMDBS and one CMDSu. We studied both the
ir anticoagulant activity and the catalysis of thrombin (T) inhibition
by heparin cofactor II (HCII) and antithrombin (AT) in the presence o
f these dextran derivatives relative to heparin and dextran sulfate (D
XSu). The anticoagulant activity of CMDBS was due both to direct throm
bin inhibition and to catalysis of thrombin inhibition by HCII. The an
ticoagulant and catalytic activities of CMDBS were related mainly to t
heir molecular weight and sulfate content. The interaction of the dext
ran derivatives with thrombin does not involve the active site of the
enzyme. A kinetic study showed that all the CMDBS exhibited higher aff
inity for thrombin than heparin did but lower affinity than DXSu did,
suggesting that the benzylamide and sulfate groups potentiate the inte
raction between the dextran derivatives and thrombin. This study shows
that the mechanism by which the dextran derivatives inhibit thrombin
is original and is related to preferential interaction with thrombin;
this both inhibits the clotting activity of the enzyme and increases t
he reaction rate of thrombin inhibition by HCII. (C) 1998 John Wiley &
Sons, Inc.